We identified two candidates for rare AD variants: a missense variant in OR51G1 and a stop-gain variant in MLKL. Subsequent in vitro functional analyses demonstrated that the MLKL loss-of-function variant plays a crucial role in the pathogenesis of AD. Here, OR51G1 is linked to Alzheimer disease.